| Breakdown | TTM | Dec 2025 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 251.78M | ― | 251.78M | 331.50M | 294.48M | 327.89M |
| Gross Profit | 181.47M | ― | 181.47M | 242.07M | 193.46M | 219.21M |
| EBITDA | 11.95M | ― | 11.95M | -561.43M | -5.58M | -160.42M |
| Net Income | -18.71M | ― | -18.71M | -588.08M | -56.25M | -310.83M |
Balance Sheet | ||||||
| Total Assets | 630.59M | ― | 630.59M | 702.36M | 1.30B | 1.32B |
| Cash, Cash Equivalents and Short-Term Investments | 87.45M | ― | 87.45M | 126.99M | 110.36M | 115.16M |
| Total Debt | 217.12M | ― | 217.12M | 295.24M | 289.33M | 286.82M |
| Total Liabilities | 479.92M | ― | 479.92M | 561.26M | 602.72M | 605.54M |
| Stockholders Equity | 150.68M | ― | 150.68M | 141.10M | 694.88M | 712.95M |
Cash Flow | ||||||
| Free Cash Flow | 46.82M | ― | 46.82M | 12.20M | 2.37M | -19.58M |
| Operating Cash Flow | 61.17M | ― | 61.17M | 17.20M | 7.50M | -2.14M |
| Investing Cash Flow | -10.55M | ― | -10.55M | 4.38M | 5.82M | -10.56M |
| Financing Cash Flow | -87.00M | ― | -87.00M | 225.00K | -5.33M | -19.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $462.00M | 55.44 | 3.87% | ― | 4.42% | 165.42% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | $501.52M | -22.50 | -12.83% | ― | -24.05% | 96.90% | |
52 Neutral | $544.62M | -15.64 | -44.64% | ― | 17.34% | -8.35% | |
50 Neutral | $482.90M | -2.13 | ― | ― | -17.50% | -51.25% | |
48 Neutral | $4.67B | -13.17 | -90.15% | ― | 120.52% | -124.81% |
Cerence, a company involved in patent disputes with Samsung, resolved its legal battles through a cross-license agreement. This agreement, reached on October 28, 2025, required Samsung to make a one-time payment of $49.5 million to Cerence, concluding a series of lawsuits filed by both parties over patent infringements.